Edgemont Pharmaceuticals, LLC — Form D
Edgemont Pharmaceuticals, LLC of MENDHAM, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-06. The offering totals $3.5M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-04-06
- Form: D
- Accession: 0000897069-10-000351
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $1.3M
- Remaining: $2.2M
- Minimum investment: $100K
- Investors: 11
- Date of first sale: 2010-03-22
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-140230
Issuer
- Name: Edgemont Pharmaceuticals, LLC
- CIK: 0001488709
- Entity type: Limited Liability Company
- Jurisdiction: NEW JERSEY
- Incorporated: 2006
- Address: 88 EAST MAIN STREET, MENDHAM, NJ, 07945
- Phone: (973) 543-2474
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Christine A Blumhardt | Executive Officer | Mendham, NJ |
| Warren A Stern | Executive Officer | Mendham, NJ |
| Mike A Vachon | Executive Officer | Mendham, NJ |
| Robert A Zerbe | Director | Grand Rapids, MI |
| Timothy A McInerney | Director | New York, NY |
| Barbara A Duncan | Director | New York, NY |
| Douglas A Saltel | Director | Mendham, NJ |
| Douglas A Saltel | Executive Officer | Mendham, NJ |
Other filings by this issuer (2)
More